Get the Stockscreener App
4.78
0.84%
0.04
After Hours:
4.84
0.06
+1.26%
Sensus Healthcare Inc stock is traded at $4.78, with a volume of 77,286.
It is up +0.84% in the last 24 hours and down -16.29% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$4.74
Open:
$4.77
24h Volume:
77,286
Relative Volume:
0.25
Market Cap:
$78.68M
Revenue:
$24.41M
Net Income/Loss:
$485.00K
P/E Ratio:
8.386
EPS:
0.57
Net Cash Flow:
$-2.37M
1W Performance:
+4.37%
1M Performance:
-16.29%
6M Performance:
-19.12%
1Y Performance:
+24.16%
1-Day Range:
$4.70
$4.84
1-Week Range:
$4.42
$4.9599
52-Week Range:
$3.09
$9.3293
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
4.78 | 78.68M | 24.41M | 485.00K | -2.37M | 0.57 |
|
ABT
Abbott Laboratories
|
127.42 | 220.99B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.73 | 148.66B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
378.05 | 144.26B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.87 | 117.97B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.90 | 41.68B | 5.72B | 4.17B | 259.90M | 6.97 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Sensus Healthcare to Participate in the 37th Annual ROTH Conference - Joplin Globe
Medical Device Leader Sensus Healthcare Sets Key Investor Meetings at ROTH Conference - StockTitan
Investors Shouldn't Be Too Comfortable With Sensus Healthcare's (NASDAQ:SRTS) Earnings - Simply Wall St
Impressive Earnings May Not Tell The Whole Story For Sensus Healthcare (NASDAQ:SRTS) - Yahoo Finance
Lake Street Capital Issues Pessimistic Forecast for Sensus Healthcare (NASDAQ:SRTS) Stock Price - Defense World
Brokers Suggest Investing in Sensus Healthcare (SRTS): Read This Before Placing a Bet - Nasdaq
Sensus Healthcare, Inc. to Host Earnings Call - accessnewswire.com
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting - Joplin Globe
Can AI Transform Dermatology? Sensus Healthcare's Game-Changing Tech Debuts at Major Conference - StockTitan
IFP Advisors Inc Buys Shares of 13,700 Sensus Healthcare, Inc. (NASDAQ:SRTS) - Defense World
Sensus Healthcare, Inc. SEC 10-K Report - TradingView
Sensus Healthcare (NasdaqCM:SRTS) Shares Dip 14% After Q4 Earnings Show US$3 Million Net Income Drop - Yahoo Finance
Sensus Healthcare reports successful keloid treatment study - Investing.com
Sensus Healthcare reports successful keloid treatment study By Investing.com - Investing.com South Africa
Can This Radiation Therapy Finally Solve the Keloid Recurrence Problem? Taiwan Study Says Yes - StockTitan
Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Implied Volatility Surging for Sensus Healthcare (SRTS) Stock Options - MSN
How the (SRTS) price action is used to our Advantage - Stock Traders Daily
Sensus Healthcare announces sale of first SRT-100 Vision System to Asia - MSN
HC Wainwright Brokers Decrease Earnings Estimates for SRTS - MarketBeat
Brokers Offer Predictions for SRTS FY2028 Earnings - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Sensus Healthcare (NASDAQ:SRTS) Stock - MarketBeat
HC Wainwright Issues Pessimistic Outlook for SRTS Earnings - Defense World
Sensus Healthcare resumes share buyback program - MSN
HC Wainwright Cuts Earnings Estimates for Sensus Healthcare - MarketBeat
Sensus Healthcare buys back shares - Medical Buyer
HC Wainwright Issues Pessimistic Estimate for SRTS Earnings - Defense World
Sensus Healthcare Resumes Common Stock Repurchase Program - Defense World
Sensus Healthcare Resumes $3 Million Share Buyback Plan -February 11, 2025 at 09:17 am EST - Marketscreener.com
Sensus Healthcare Unlocks $3M War Chest for Strategic Share Repurchases | SRTS - StockTitan
(SRTS) Technical Pivots with Risk Controls - Stock Traders Daily
FY2028 Earnings Estimate for SRTS Issued By Roth Capital - Defense World
Sensus Healthcare (NASDAQ:SRTS) Price Target Raised to $12.00 at HC Wainwright - Defense World
Sensus Healthcare’s Strong Revenue Growth and Strategic Initiatives Justify Buy Rating - TipRanks
Sensus Healthcare anticipates significant revenue from FDA agreements in H2 2025 - MSN
Sensus Healthcare (NASDAQ:SRTS) Announces Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Revenue Beat: Sensus Healthcare, Inc. Beat Analyst Estimates By 5.6% - Simply Wall St
Sensus Healthcare, Inc. Just Beat Revenue By 5.6%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Sensus Healthcare Inc (NASDAQ: SRTS) Has Advanced 70.49% In 2025; Is The Share Price Attractive Enough At $10? - Marketing Sentinel
Sensus Healthcare Inc (SRTS) stock: A year of ups and downs - US Post News
Sensus Healthcare: A Tough Q1 2025 Awaits Ahead (NASDAQ:SRTS) - Seeking Alpha
Closing Figures Unveiled: Sensus Healthcare Inc (SRTS) Drop -32.37, Closes at 6.08 - The Dwinnex
Sensus Healthcare Inc [SRTS] Records 200-Day SMA of $6.33 - Knox Daily
Sensus Healthcare Earnings Call Highlights Robust Growth - TipRanks
Stock market news: SunCar Technology Group -37.56%, Sensus Healthcare -32.04% among biggest losers during mid day trading - Business Upturn
Stock market today: Sensus Healthcare -32.26%, SunCar Technology Group -27.90% among biggest losers in early trading - Business Upturn
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2024 Earnings Call Transcript - Insider Monkey
Sensus Healthcare Inc (SRTS) Q4 2024 Earnings Call Highlights: S - GuruFocus.com
Sensus Healthcare Inc (SRTS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
Sensus Healthcare Announces Strong 2024 Financial Results - TipRanks
Sensus Healthcare, Inc. (SRTS) Lags Q4 Earnings Estimates - Yahoo Finance
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Feb 10 '25 |
Buy |
5.95 |
1,000 |
5,950 |
115,839 |
| Heinrich John | Director |
May 20 '24 |
Sale |
6.24 |
15,227 |
95,016 |
59,940 |
| Heinrich John | Director |
May 17 '24 |
Sale |
5.95 |
4,773 |
28,399 |
75,167 |
1.34%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):